Angiodynamics (ANGO) Finished Goods (2012 - 2014)

Angiodynamics' (ANGO) quarterly Finished Goods came in at $23.2 million in Q1 2014, down 4.32% on a QoQ basis from $24.2 million in Q4 2013.

Angiodynamics (ANGO) Finished Goods (2012 - 2014) Analysis & Trends

Angiodynamics (ANGO) has 3 years of Finished Goods data on file, last reported at $23.2 million in Q1 2014.

Quarterly Finished Goods changed N/A year-over-year to $23.2 million in Q1 2014, while the trailing twelve-month figure through Feb 2014 was $23.2 million (changed N/A YoY) and the FY2013 annual result came in at $25.7 million, down 6.0% from the prior year.
Finished Goods retreated to $23.2 million in Q1 2014, from $24.2 million in the prior quarter.
In the past five years, Finished Goods ranged from a high of $32.6 million in Q3 2012 to a low of $23.2 million in Q1 2014.
A 3-year average of $26.4 million and a median of $25.7 million in 2013 frame the typical range for Finished Goods.
The widest YoY moves for Finished Goods: up 6.0% in 2013, down 21.3% in 2013.
Tracing ANGO's Finished Goods over 3 years: stood at $32.6 million in 2012, then decreased by 25.63% to $24.2 million in 2013, then fell by 4.32% to $23.2 million in 2014.
The last three Finished Goods figures came in at $23.2 million (Q1 2014), $24.2 million (Q4 2013), and $25.6 million (Q3 2013), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn
10	Angiodynamics	658.19 Mn	604.32 Mn	46.77 Mn

Download Data